logo

FMS

Fresenius Medical·NYSE
--
--(--)
--
--(--)

FMS fundamentals

Fresenius Medical (FMS) expects to report earnings on Feb 24, 2026, with estimated revenue of 5.61B (YoY +5.42%), and EPS at 0.6472 (YoY +35.48%).
Revenue estimate / YoY
5.61B
+5.42%
EPS estimate / YoY
0.6472
+35.48%
Report date
Feb 24, 2026
EPS
Revenue

Revenue & Expenses

FMS has released its 2025 Q3 earnings report, with revenue of 5.73B, reflecting a YoY change of 8.05%, and net profit of 384.14M, showing a YoY change of 30.56%. The Sankey diagram below clearly presents FMS's revenue sources and cost distribution.

Key Indicators

Fresenius Medical (FMS) key financial stats and ratios, covering profitability, financial health, and leverage.
Fresenius Medical (FMS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Fresenius Medical (FMS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Fresenius Medical (FMS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Fresenius Medical (FMS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Fresenius Medical (FMS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield